Skip to content

A Clinical Trial Testing Root Coverage With Acellular Dermal Matrix in Thin and Thick Gingival Biotypes

Acellular Dermal Matrix Combined With Coronally Advanced Flap in the Treatment of Multiple Recession Defects in Thin Versus Thick Periodontal Biotype Population: A Controlled Clinical Investigation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03057730
Enrollment
34
Registered
2017-02-20
Start date
2015-08-31
Completion date
2025-09-30
Last updated
2024-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession

Keywords

acellular dermal matrix

Brief summary

Gingival recession is a common defect among the American population. It is also a major cause for root decay, hypersensitivity, contributes to tooth mobility and low self-esteem. Acellular dermal matrix, a human-derived grafting material has been put on the market for the treatment of gingival recession. Treating gingival recession with this material has been a validated treatment option for years. However, treatment outcomes in two patient populations, namely those with thin biotypes and those with thick biotypes, has not been investigated. This study will observe the primary treatment outcomes in the two patient groups at 5 time points - 3 months, 6 months and 12 months post-surgery to observe short term outcomes; additional 24 months and 48 months post-surgery to observe long term outcomes.

Detailed description

The study aim is to evaluate and compare the use of acellular dermal matrix, a material used for treating gum recession, in two study populations, namely thin or thick gingival biotype. Short term outcomes and the long term stability of ADM in recession repair between thick and thin biotypes will be evaluated. There will be two study groups, namely thin and thick groups. The included subjects will be divided in two groups according to gingival thickness: Thin gingival biotype group (TnB): \< 0.8 mm, thick gingival biotype group (TkB) ≥ 0.8 mm. Each subject will be in one of the two groups only. Randomization will not be used to assign the subjects to the study groups, because the intervention will be the same for both groups, namely ADM applied beneath a coronally advanced flap. The short term (3 months, 6 months post-surgery) outcomes and the longer term (12 months, 24 months and 48 months post-surgery) outcomes will further be compared within the groups and between the groups.

Interventions

ADM is a human-derived allograft material, treated to remove all cellular components so that only the connective tissue matrix remains.

Sponsors

Tufts University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects must be current patients of Tufts University School of Dental Medicine * Subjects with two Miller class I or class II adjacent recessions with a recession height ≥ 2 mm and \< 4 mm * Affected tooth/teeth are anterior- incisors, canines or premolars (except the mandibular central and lateral incisors) * Healthy subjects with no contraindications to root coverage surgery * Subjects with full-mouth plaque index\<1 and gingival index\<1, calculated as the average value of plaque index and gingival index

Exclusion criteria

* Presence of adjacent defects, whose gingival thickness values place them in a different category other than thick or thin biotype * Areas that have previously been treated with root coverage surgeries * Subjects with a known hypersensitivity to polysorbate 20 (contraindicated with the use of Alloderm®) * Subject smokes more than 5 cigarettes per day * Subjects with systemic conditions which influence wound healing * Subjects that are pregnant or lactating * Subjects with a condition causing immunosuppression, or currently taking immunosuppressant medications * Teeth with severe occlusal interferences, deep cervical lesions, or large restorations whose margins impinge on the cement-enamel junction or make identification of this landmark impossible

Design outcomes

Primary

MeasureTime frameDescription
Change in Mean Root CoverageUp to 48 months post surgeryRoot coverage will be measured in mm using a probe and digital caliper. Mean root coverage will be measured per patient by averaging the two study teeth. Change in mean root coverage for the primary outcome will be assessed by the difference between the baseline mean root coverage and the final mean root coverage at 48 months post surgery.

Secondary

MeasureTime frameDescription
Change in Clinical Attachment Level (CAL)Up to 48 months post surgeryCAL will be measured from the base of the pocket to the cementoenamel junction (CEJ) in mm using a probe and digital caliper. Change in CAL will be assessed from baseline to 48 months post surgery.
Change in Recession Height (RH)Up to 48 months post surgery
Change in Recession Width (RW)Up to 48 months post surgery
Change in Clinical Probing Depth (CPD)Up to 48 months post surgery
Change in Gingival Thickness (GT)Up to 48 months post surgery
Complete Root Coverage (CRC)Up to 48 months post surgeryCRC will be assessed using descriptive statistics (# subjects with CRC out of the total sample)
Change in Keratinized Tissue WidthUp to 48 months post surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026